- Report
- January 2026
- 492 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 235 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 407 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 378 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 392 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 286 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 372 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 204 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 282 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 367 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 361 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 384 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 386 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 144 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 114 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 183 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 179 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 258 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 194 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 196 Pages
Global
From €5204EUR$5,850USD£4,516GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more